Cardinal Health Inc (CAH) Holding Grow by GHP Investment Advisors Inc.

Cardinal Health Inc (CAH) Holding Grow by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. increased its position in Cardinal Health Inc (NYSE:CAH) by 1.6% during the first quarter, Holdings Channel reports. The institutional investor owned 15,777 shares of the company’s stock after buying an additional 255 shares during the period. GHP Investment Advisors Inc.’s holdings in Cardinal Health were worth $1,287,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Massmutual Trust Co. FSB ADV bought a new stake in shares of Cardinal Health during the fourth quarter worth $101,000. Advisory Services Network LLC bought a new stake in shares of Cardinal Health during the first quarter worth $120,000. SRB Corp boosted its stake in shares of Cardinal Health by 4.6% in the third quarter. SRB Corp now owns 1,914 shares of the company’s stock worth $149,000 after buying an additional 84 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock worth $156,000 after buying an additional 116 shares in the last quarter. Finally, Northwest Quadrant Wealth Management LLC bought a new stake in shares of Cardinal Health during the fourth quarter worth $173,000. 85.84% of the stock is owned by institutional investors.

Cardinal Health Inc (NYSE CAH) traded up 0.99% during trading on Friday, reaching $75.79. The company’s stock had a trading volume of 3,086,614 shares. The firm’s 50-day moving average is $73.17 and its 200-day moving average is $75.94. Cardinal Health Inc has a 52-week low of $62.70 and a 52-week high of $85.52. The stock has a market cap of $23.94 billion, a P/E ratio of 18.09 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Monday, May 1st. The company reported $1.53 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.07. The business had revenue of $31.82 billion during the quarter, compared to analysts’ expectations of $32.30 billion. Cardinal Health had a return on equity of 25.52% and a net margin of 1.06%. Cardinal Health’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter last year, the company posted $1.43 earnings per share. Equities research analysts forecast that Cardinal Health Inc will post $5.35 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, July 15th. Shareholders of record on Monday, July 3rd will be given a dividend of $0.4624 per share. The ex-dividend date of this dividend is Thursday, June 29th. This is an increase from Cardinal Health’s previous quarterly dividend of $0.45. This represents a $1.85 annualized dividend and a yield of 2.44%. Cardinal Health’s dividend payout ratio (DPR) is 43.17%.

A number of analysts have weighed in on the company. William Blair cut Cardinal Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, April 19th. Barclays PLC reaffirmed an “overweight” rating and issued a $82.00 price target (down previously from $88.00) on shares of Cardinal Health in a research report on Saturday, April 22nd. Zacks Investment Research cut Cardinal Health from a “hold” rating to a “sell” rating in a research report on Friday, February 10th. Jefferies Group LLC assumed coverage on Cardinal Health in a research report on Wednesday, May 17th. They issued a “hold” rating and a $77.00 price target for the company. Finally, Leerink Swann set a $72.00 price target on Cardinal Health and gave the stock a “hold” rating in a research report on Friday, April 21st. One research analyst has rated the stock with a sell rating, sixteen have given a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $82.64.

In other Cardinal Health news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the firm’s stock in a transaction that occurred on Friday, May 12th. The shares were sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the completion of the sale, the insider now directly owns 55,440 shares in the company, valued at $4,039,912.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.94% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “CAH”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).

Related posts

Leave a Comment